Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-11-30 Share Issue/Capital Cha…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Change in number of shares and votes in Episurf Medical
Share Issue/Capital Change Classification · 98% confidence The document is a 'Company Announcement' dated November 30, 2016, detailing a 'Change in number of shares and votes in Episurf Medical' due to conversions of class A shares to class B shares. This directly relates to a change in the company's capital structure (share count and voting rights). This aligns best with the 'Share Issue/Capital Change' definition (Code: SHA). It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). The final paragraph mentions the information is made public pursuant to the Financial Instruments Trading Act, suggesting a regulatory disclosure, but the content is specifically about share capital changes.
2016-11-30 English
Förändring av antalet aktier och röster i Episurf Medical
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release dated November 30, 2016, titled "Förändring av antalet aktier och röster i Episurf Medical" (Change in the number of shares and votes in Episurf Medical). It explicitly details the conversion of A-shares to B-shares, resulting in a change in the total number of shares and votes. This directly relates to a change in the company's capital structure or share count. Based on the definitions, this fits best under 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, or potentially 'Transaction in Own Shares' (POS) if it were a buyback, but conversion/reclassification is more aligned with SHA. Since it is a direct notification of a change in the number of shares outstanding, SHA is the most appropriate classification.
2016-11-30 Swedish
Episurf Medical uppnår ny milstolpe med 150 implantat
Regulatory Filings Classification · 99% confidence The document is titled "Pressmeddelande" (Press Release) and announces a business milestone (150 implants reached) and includes quotes from the CEO and Medical Advisor regarding product adoption and patient outcomes. It concludes with a statement that the information is required to be made public under the EU Market Abuse Regulation (MAR) and provides contact details. This structure is characteristic of a general corporate announcement or news release, rather than a formal financial filing like a 10-K, IR, or ER. Since it is a general announcement that doesn't fit the specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory disclosure mechanism.
2016-11-28 Swedish
Episurf Medical achieves milestone of 150th implant
Regulatory Filings Classification · 99% confidence The document is titled "Company Announcement" and details a specific operational milestone (150th implant) achieved by Episurf Medical, including quotes from the CEO and Medical Advisor. It is not a formal financial report (like 10-K or IR), nor is it a transcript, proxy statement, or dividend notice. It is a general update about company progress and adoption of its product. Since it is a general, non-financial, non-management change announcement that doesn't fit the specific categories like AGM-R, ER, or MANG, it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is explicitly stated that the information is made public pursuant to the EU Market Abuse Regulation.
2016-11-28 English
Episurf Medical AB to present at Stora Aktiedagen, held in Stockholm on November 28
Regulatory Filings Classification · 95% confidence The document is a short company announcement dated November 21, 2016, stating that Episurf Medical AB will present at an investor conference ('Stora Aktiedagen') on November 28. It provides details about the event and mentions that the presentation will be available on the company's website. Since this is a short announcement about an upcoming event/presentation rather than the presentation itself, and it doesn't fit the specific categories like ER, DIV, or DIRS, it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous official company announcements not covered elsewhere. It is not an Investor Presentation (IP) because it is announcing attendance, not providing the presentation content itself.
2016-11-21 English
Episurf Medical AB presenterar vid Stora Aktiedagen den 28 november i Stockholm
Regulatory Filings Classification · 95% confidence The document is a short press release (1524 characters) dated November 21, 2016, announcing that Episurf Medical AB will be presenting at an event called 'Stora Aktiedagen' (The Big Shareholder Day) on November 28th. It explicitly states that the presentation will be made available on the company's website. This structure—announcing participation in an event where a presentation will be given, and stating the presentation will be published later—fits the definition of a Report Publication Announcement (RPA), as it is an announcement about the future availability or release of investor-related material, rather than the material itself (like an IP or ER). It is not a formal regulatory filing like a 10-K or an ER, but rather a notice about an investor event presentation.
2016-11-21 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.